Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) EBITDA Margin (2018 - 2025)

Historic EBITDA Margin for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to 17.96%.

  • Health Catalyst's EBITDA Margin fell 41000.0% to 17.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 24.67%, marking a year-over-year decrease of 6700.0%. This contributed to the annual value of 18.59% for FY2024, which is 200300.0% up from last year.
  • Health Catalyst's EBITDA Margin amounted to 17.96% in Q3 2025, which was down 41000.0% from 41.49% recorded in Q2 2025.
  • Over the past 5 years, Health Catalyst's EBITDA Margin peaked at 13.87% during Q3 2024, and registered a low of 66.08% during Q4 2021.
  • In the last 5 years, Health Catalyst's EBITDA Margin had a median value of 41.49% in 2025 and averaged 38.03%.
  • Per our database at Business Quant, Health Catalyst's EBITDA Margin skyrocketed by 333800bps in 2023 and then plummeted by -247500bps in 2025.
  • Over the past 5 years, Health Catalyst's EBITDA Margin (Quarter) stood at 66.08% in 2021, then grew by 27bps to 48.5% in 2022, then rose by 18bps to 39.54% in 2023, then surged by 55bps to 17.84% in 2024, then decreased by -1bps to 17.96% in 2025.
  • Its EBITDA Margin stands at 17.96% for Q3 2025, versus 41.49% for Q2 2025 and 20.87% for Q1 2025.